Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Characterization and Clinical Management of Dilated Cardiomyopathy
| Characterization and Clinical Management of Dilated Cardiomyopathy |
| Autore | Merlo Marco |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 electronic resource (232 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
SCN5A
cardiac sodium channel cardiac channelopathy dilated cardiomyopathy precision medicine arrhythmias atrial fibrillation cardiomyopathy heart failure supraventricular arrhythmia systolic dysfunction tachycardiomyopathy ventricular arrhythmia left atrial strain cardiac resynchronization therapy muscular dystrophy calcium heart gene therapy phospholamban Serca2a mdx oxidative stress membrane stabilization left ventricular noncompaction congenital heart disease congestive heart failure non-ischemic cardiomyopathy genetics desmin mitochondrial dysfunction myopathy whole exome sequencing laminopathy LMNA biomarkers troponin T NT-proBNP malignant ventricular arrhythmia arrhythmic risk stratification DNA methylation alternative splicing epigenetics nonischemic dilated cardiomyopathy cardiac magnetic resonance imaging late gadolinium enhancement long axis strain left ventricle sphericity index major adverse cardiovascular events sex differences left ventricular reverse remodelling long-term outcomes left ventricle non-compaction cardiomyopathy cardiac magnetic resonance titin RNA binding motif protein 20 (RBM20) sarcomere diastolic dysfunction phosphorylation non-sense mRNA decay mammalian target of rapamycin (mTOR) complex-1 duchenne muscular distrophy |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557595503321 |
Merlo Marco
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical Studies, Big Data, and Artificial Intelligence in Nephrology and Transplantation
| Clinical Studies, Big Data, and Artificial Intelligence in Nephrology and Transplantation |
| Autore | Cheungpasitporn Wisit |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 electronic resource (374 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
tacrolimus
C/D ratio tacrolimus metabolism everolimus conversion kidney transplantation gut microbiome renal transplant recipient diarrhea immunosuppressive medication gut microbiota 16S rRNA sequencing butyrate-producing bacteria Proteobacteria torquetenovirus immunosuppression transplantation immunosuppressed host outcome renal transplantation Goodpasture syndrome anti-GBM disease epidemiology hospitalization outcomes acute kidney injury risk prediction artificial intelligence patent ductus arteriosus conservative management blood pressure eradication interferon-free regimen hepatitis C infection kidney transplant allograft steatosis lipopeliosis transplant numbers live donors public awareness Google TrendsTM machine learning big data nephrology chronic kidney disease NLR PLR RPGN predictive value hemodialysis withdrawal cellular crescent global sclerosis procurement kidney biopsy glomerulosclerosis minimally-invasive donor nephrectomy robot-assisted surgery laparoscopic surgery organ donation living kidney donation MeltDose® LCPT renal function liver transplantation metabolism erythropoietin fibroblast growth factor 23 death weekend effect in-hospital mortality comorbidity dialysis elderly klotho α-Klotho FGF-23 kidney donor Nephrology CKD-MBD CKD-Mineral and Bone Disorder deceased donor Eurotransplant Senior Program risk stratification intensive care kidney transplant recipients long-term outcomes graft failure cardiovascular mortality lifestyle inflammation vascular calcification bone mineral density dual-energy X-ray absorptiometry living donation repeated kidney transplantation graft survival prolonged ischaemic time patient survival pre-emptive transplantation metabolomics urine acute rejection allograft cystatin C hyperfiltration kidney injury molecule (KIM)-1 tubular damage genetic polymorphisms (cardiac) surgery inflammatory cytokines clinical studies chronic kidney disease (CKD) no known kidney disease (NKD) ICD-10 billing codes phenotyping electronic health record (EHR) estimated glomerular filtration rate (eGFR) machine learning (ML) generalized linear model network (GLMnet) random forest (RF) artificial neural network (ANN), clinical natural language processing (clinical NLP) discharge summaries laboratory values area under the receiver operating characteristic (AUROC) area under the precision-recall curve (AUCPR) fibrosis extracellular matrix collagen type VI living-donor kidney transplantation ethnic disparity |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557367503321 |
|
Cheungpasitporn Wisit
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Novel Biomarkers for Heart Disease
| Novel Biomarkers for Heart Disease |
| Autore | Lichtenauer Michael |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 electronic resource (420 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
diet quality
ceramides obesity cardiovascular risk healthy eating index carbohydrate antigen-125 heart failure inflammatory marker older women biomarker cardiometabolic disease epicardial adipose tissue epicardial fat epicardial fat volume microRNA thyroid-stimulating hormone cardiometabolic risks metabolic syndrome hypertension very low-density lipoprotein STIM1 SOCE atrial myopathy atrial fibrillation ejection fraction soluble urokinase-type plasminogen activator receptor (suPAR) growth differentiation factor 15 (GDF-15) heart-type fatty acid-binding protein (H-FABP) soluble suppression of tumorigenicity 2 (sST2) acute myocardial infarction biomarkers catestatin coronary artery disease heart failure decompensation left ventricular ejection fraction troponin NT-proBNP NYHA functional class GDF-15 cardiovascular surgery operative risk muscle wasting sarcopenia renal dysfunction chronic kidney disease aortic disease aneurysm miRNA TGF-β pathway KLF4 synthetic phenotype aortic regurgitation echocardiography magnetic resonance imaging vena contracta area longitudinal strain T1 mapping GDF8 myostatin AMI ceruloplasmin H-FABP heart-type fatty acid-binding protein FABP3 fatty acid-binding protein 3 HF cardiac biomarkers cardiac magnetic resonance imaging left ventricular systolic function magnetic resonance spectroscopy myocardial triglyceride content cell adhesion molecule repeated measurements pregnancy-associated plasma protein-A cohort studies cardiovascular diseases mitochondrial dysfunction circulating cells PBMCS platelets oxidative stress reactive oxygen species (ROS) mitochondrial DNA (mtDNA) herat failure liver-type fatty-acid-binding protein long-term outcomes cardiac intensive care units acute kidney injury myocardial infarction STEMI cardiovascular events cardiovascular death risk stratification sST2 Pentraxin-3 sudden cardiac death ventricular arrhythmia ventricular tachycardia chronic heart failure saliva salivary biomarkers CKD CVD PPCI left ventricular adverse remodelling circulating miRNAs NAFLD Framingham risk score risk prediction secondary prevention primary prevention NAFLD fibrosis score HFpEF HFrEF suPAR |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557546203321 |
|
Lichtenauer Michael
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||